Live
Endpoints NewsBioNTech to scale down manufacturing, over 1,800 jobs on the lineEndpoints NewsParsley Health goes in-network nationwideBioPharma DiveViridian data lift prospects for thyroid eye disease drugFierceBiotechOlympus, EndoRobotics in distribution pact for robot-assisted endoscopic techBioWorldUCB onboards more autoimmune TCEs with $2.2B Candid buyBioWorldChina’s new IIT rules could reshape early stage drug developmentBioWorldBeone eyes Huahui Health’s trispecific HH-160 with $2B option dealBioWorldBio Korea 2026: US policy risks shift to execution frameworkBioWorldBio Korea 2026 kicks off with spotlight on oligonucleotidesEndpoints NewsSecond life for gene therapy; Takeda Phase 2/3 win; UK cancer biotech's $83MFierceBiotechMadrigal continues MASH deal spree with $1B biobucks license for Arrowhead asset rejected by J&JEndpoints NewsSwiss manufacturing, biotech industry so far unfazed by geopolitics
This story is not available in the archive.